We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Revolutionary Bio-Hydrogel Implant Coating Could Reduce Risk of Device Rejection

By HospiMedica International staff writers
Posted on 27 Jul 2023

The ongoing fight against infections and microbial resistance continues to pose significant challenges in healthcare. More...

Implant-associated infections, for instance, heighten the risk of device rejection, thereby endangering patient health and adding to the increasing problem of antimicrobial resistance. Conventional treatments, including lengthy antibiotic courses, often fall short against such resilient bacterial communities, further complicating the problem. Now, a new initiative is taking a bold and innovative approach to address this issue by shifting from the conventional method of directly combating pathogenic bacteria to instead harness them as beneficial allies in enhancing tissue regeneration for improved implant integration. This groundbreaking perspective could bring about a paradigm shift in managing infections.

The Bioaction (Europe) project, a collaboration involving four research centers, two universities, and two companies from five European countries, is set to develop functional bio-hydrogels. These hydrogels are designed to trigger local remodeling of physiological processes to expedite healing and stimulate bone growth. They will be designed as injectable materials or implant coatings for minimally invasive applications. Over the next four years, the project's researchers will validate this technology using clinically relevant models for dental implants and permanent transcutaneous prostheses. However, the transformative influence of Bioaction reaches beyond these specific applications. By reducing dependence on extended antibiotic treatments and minimizing failure rates, this trailblazing project has the potential to revolutionize methods of treating infections. Ultimately, Bioaction aims to enhance patient quality of life while making a significant contribution to the global fight against antimicrobial resistance.

“The Bioaction project proposes a visionary approach that will be pursued thanks to real interdisciplinarity,” said Luigi Ambrosio, project coordinator. “Our partners’ diverse expertise and skills in synthetic biology, biomaterials, microbiology, and beyond will surely be the basis for the project’s success.”

Related Links:
Bioaction


Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Anesthesia Cart
UTGSU-333369-DKB
New
Thoracolumbar & Sacropelvic System
Ennovate TLSP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: the deep tissue in vivo sound printing (DISP) platform, which combines ultrasound with low-temperature–sensitive liposomes loaded with crosslinking agents (Photo courtesy of Elham Davoodi and Wei Gao/Caltech)

New Ultrasound-Guided 3D Printing Technique to Help Fabricate Medical Implants

3D bioprinting technologies hold considerable promise for advancing modern medicine by enabling the production of customized implants, intricate medical devices, and engineered tissues designed to meet... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.